Published 21 November 2005. doi:10.1083/jcb.200505098
The Rockefeller University Press, 0021-9525 $8.00
JCB, Volume 171, Number 4, 663-673
Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model
Wa Xian,
Kathryn L. Schwertfeger,
Tracy Vargo-Gogola, and
Jeffrey M. Rosen
Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030
Correspondence to Jeffrey M. Rosen: jrosen{at}faculty.bcm.tmc.edu
Members of the fibroblast growth factor (FGF) family and the FGF receptors (FGFRs) have been implicated in mediating various aspects of mammary gland development and transformation. To elucidate the molecular mechanisms of FGFR1 action in a context that mimics polarized epithelial cells, we have developed an in vitro three-dimensional HC11 mouse mammary epithelial cell culture model expressing a drug-inducible FGFR1 (iFGFR1). Using this conditional model, iFGFR1 activation in these growth-arrested and polarized mammary acini initially led to reinitiation of cell proliferation, increased survival of luminal cells, and loss of cell polarity, resulting in the disruption of acinar structures characterized by the absence of an empty lumen. iFGFR1 activation also resulted in a gain of invasive properties and the induction of matrix metalloproteinase 3 (MMP-3), causing the cleavage of E-cadherin and increased expression of smooth muscle actin and vimentin. The addition of a pan MMP inhibitor abolished these phenotypes but did not prevent the effects of iFGFR1 on cell proliferation or survival.
Abbreviations used in this paper: 2D, two-dimensional; 3D, three-dimensional; CSF-1R, colony-stimulating factor receptor; EMT, epithelial-to-mesenchymal transition; ERK, extracellular regulated kinase; FGFR, FGF receptor; iFGFR, inducible FGFR; MMP, matrix metalloproteinase; p-ERM, phospho-ezrin/radixin/moesin; p-histone H3, phosphorylated histone H3; RTK, tyrosine kinase receptor; siRNA, small interfering RNA; SMA, smooth muscle actin.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
-
Cowden Dahl, K. D., Symowicz, J., Ning, Y., Gutierrez, E., Fishman, D. A., Adley, B. P., Stack, M. S., Hudson, L. G.
(2008). Matrix Metalloproteinase 9 Is a Mediator of Epidermal Growth Factor-Dependent E-Cadherin Loss in Ovarian Carcinoma Cells. Cancer Res.
68: 4606-4613
[Abstract]
[Full Text]
-
Kondo, T., Zheng, L., Liu, W., Kurebayashi, J., Asa, S. L., Ezzat, S.
(2007). Epigenetically Controlled Fibroblast Growth Factor Receptor 2 Signaling Imposes on the RAS/BRAF/Mitogen-Activated Protein Kinase Pathway to Modulate Thyroid Cancer Progression. Cancer Res.
67: 5461-5470
[Abstract]
[Full Text]
-
Xian, W., Schwertfeger, K. L., Rosen, J. M.
(2007). Distinct Roles of Fibroblast Growth Factor Receptor 1 and 2 in Regulating Cell Survival and Epithelial-Mesenchymal Transition. Mol. Endocrinol.
21: 987-1000
[Abstract]
[Full Text]
-
Yang, Z. Q., Streicher, K. L., Ray, M. E., Abrams, J., Ethier, S. P.
(2006). Multiple Interacting Oncogenes on the 8p11-p12 Amplicon in Human Breast Cancer. Cancer Res.
66: 11632-11643
[Abstract]
[Full Text]
-
Halbleib, J. M., Nelson, W. J.
(2006). Cadherins in development: cell adhesion, sorting, and tissue morphogenesis. Genes Dev.
20: 3199-3214
[Abstract]
[Full Text]
-
Reis-Filho, J. S., Simpson, P. T., Turner, N. C., Lambros, M. B., Jones, C., Mackay, A., Grigoriadis, A., Sarrio, D., Savage, K., Dexter, T., Iravani, M., Fenwick, K., Weber, B., Hardisson, D., Schmitt, F. C., Palacios, J., Lakhani, S. R., Ashworth, A.
(2006). FGFR1 Emerges as a Potential Therapeutic Target for Lobular Breast Carcinomas.. Clin. Cancer Res.
12: 6652-6662
[Abstract]
[Full Text]
-
Schwertfeger, K. L., Xian, W., Kaplan, A. M., Burnett, S. H., Cohen, D. A., Rosen, J. M.
(2006). A Critical Role for the Inflammatory Response in a Mouse Model of Preneoplastic Progression. Cancer Res.
66: 5676-5685
[Abstract]
[Full Text]
-
Ginger, M. R., Shore, A. N., Contreras, A., Rijnkels, M., Miller, J., Gonzalez-Rimbau, M. F., Rosen, J. M.
(2006). A noncoding RNA is a potential marker of cell fate during mammary gland development. Proc. Natl. Acad. Sci. USA
103: 5781-5786
[Abstract]
[Full Text]